Evaluation of the potency and investigation of the molecular mechanism of actions of LCL161 in hu-man breast cancer cells
碩士 === 國立成功大學 === 藥理學研究所 === 105
Main Authors: | Wei-EnWeng, 翁薇恩 |
---|---|
Other Authors: | Chun Hei Antonio Cheung |
Format: | Others |
Language: | en_US |
Published: |
2017
|
Online Access: | http://ndltd.ncl.edu.tw/handle/n9x6vz |
Similar Items
-
Investigation of the potency and the molecular mechanism of actions of LCL161 in MDR1-expressing multidrug-resistant cancer cells
by: Tsung-HanYang, et al.
Published: (2017) -
Smac mimetics LCL161 and GDC-0152 inhibit osteosarcoma growth and metastasis in mice
by: Tanmay M. Shekhar, et al.
Published: (2019-09-01) -
An Updated Review of Smac Mimetics, LCL161, Birinapant, and GDC-0152 in Cancer Treatment
by: Yung-Chieh Chang, et al.
Published: (2021-12-01) -
The SMAC mimetic LCL-161 selectively targets JAK2V617F mutant cells
by: Brianna M. Craver, et al.
Published: (2020-01-01) -
Architecture-Aware Instruction-Based Power Model Considering Voltage and Frequency Scaling For ESL Virtual Platforms
by: Pei-EnWeng, et al.
Published: (2012)